Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Predictive Biomarker Analysis from the GBT021601 Survival Study in Townes Sickle Mice

Mira Patel Pochron, Jiaxin Sun, Alka A Potdar, Carsten Alt, Francis DeGuzman, Michael W. Connor, Brian Cathers, Kobina Dufu, David R Archer

Blood (2023) 142 (Supplement 1): 14.

https://doi.org/10.1182/blood-2023-177776

Published: 2023

Journal Articles

GBT021601 Inhibits HbS Polymerization, Prevents RBC Sickling and Improves the Pathophysiology of Sickle Cell Disease in a Murine Model

Kobina Dufu, PhD, Carsten Alt, MSc, PhD, Steven Strutt, PhD, Tzechiang Tang, Hilary Liao-Zou, Yue Yuan, Brian E Cathers, PhD, Donna Oksenberg, PhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-140539

Published: 2020

Journal Articles

Pharmacological Increase of Hb-O 2 Affinity with a Voxelotor Analog Does Not Decrease Brain Tissue pO 2 or Limit O 2 Extraction in Brain Tissues of Sickle Cell Mice

Kobina Dufu, PhD, Alfredo Lucas, MS, Cynthia Rodrigues Muller, PhD, Alexander T Williams, MS, Xinchun Zhang, MS, Peter Rademacher, PhD, Carsten Alt, MSc, PhD, Donna Oksenberg, PhD, Pedro Cabrales, PhD

Blood (2019) 134 (Supplement_1): 3564.

https://doi.org/10.1182/blood-2019-129282

Published: 2019

Journal Articles

Long-Acting, Oxidation-Resistant IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Wild-Type IL-33, G-CSF or AMD3100

Carsten Alt, PhD, Faye Wu, Basha Stankovich, PhD, Joy Calaoagan, Sandra Schopies, Josephine Wu, Perry Liu, Billy Wong, Katalin Kauser, MD PhD, Peter Bringmann, PhD, JUN Shen, MD, Doug Schneider, Ying Zhu, MD, Thomas Thompson, Shaun M. Lippow, PhD, Shujun Yuan, PhD, Maxine Bauzon

Blood (2017) 130 (Supplement 1): 3202.

https://doi.org/10.1182/blood.V130.Suppl_1.3202.3202

Published: 2017

Journal Articles

GBT1118 Diminishes Vaso-Occlusion in Sickle Cell Disease Mice

Carsten Alt, PhD, Perry Liu, Chien-Ming Li, PhD, Abel Silva, Peter Rademacher, PhD, Hilary Zou, Mira Patel, PhD, Kobina Dufu, PhD, Donna Oksenberg, PhD, Katalin Kauser, MD PhD

Blood (2017) 130 (Supplement 1): 3516.

https://doi.org/10.1182/blood.V130.Suppl_1.3516.3516

Published: 2017

NARROW

Predictive Biomarker Analysis from the GBT021601 Survival Study in Townes Sickle Mice

GBT021601 Inhibits HbS Polymerization, Prevents RBC Sickling and Improves the Pathophysiology of Sickle Cell Disease in a Murine Model

Pharmacological Increase of Hb-O 2 Affinity with a Voxelotor Analog Does Not Decrease Brain Tissue pO 2 or Limit O 2 Extraction in Brain Tissues of Sickle Cell Mice

Long-Acting, Oxidation-Resistant IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Wild-Type IL-33, G-CSF or AMD3100

GBT1118 Diminishes Vaso-Occlusion in Sickle Cell Disease Mice

Email alerts

ASH Publications

American Society of Hematology

Predictive Biomarker Analysis from the GBT021601 Survival Study in Townes Sickle Mice

GBT021601 Inhibits HbS Polymerization, Prevents RBC Sickling and Improves the Pathophysiology of Sickle Cell Disease in a Murine Model

Pharmacological Increase of Hb-O 2 Affinity with a Voxelotor Analog Does Not Decrease Brain Tissue pO 2 or Limit O 2 Extraction in Brain Tissues of Sickle Cell Mice

Long-Acting, Oxidation-Resistant IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Wild-Type IL-33, G-CSF or AMD3100

GBT1118 Diminishes Vaso-Occlusion in Sickle Cell Disease Mice

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only